Home > Healthcare > Medical Devices > Medical Supplies > Pen Needles Market
Pen Needles Market size was valued at over USD 2.1 billion in 2022 and is estimated to reach around USD 6.1 billion by 2032. Diabetes, especially type 2 diabetes, is on the rise worldwide. As more individuals are diagnosed with diabetes, there is a higher demand for insulin delivery devices such as pen needles, which are an essential component for administering insulin via subcutaneous injections.
For instance, according to National Diabetes Statistics Report for 2022, diabetes affected 37.3 million individuals, or 11.3% of the population in the U.S. and it has been diagnosed in an estimated 28.7 million people. In addition, according to Centers for Disease Control and Prevention (CDC), over 37 million Americans have diabetes, with around 90-95% of them having type 2 diabetes. Type 2 diabetes is most common in people over the age of 45, although it is also growing more prevalent in children, teenagers, and young adults.
Moreover, improved awareness of diabetes, its risk factors, and advancements in diagnostic methods have led to more individuals being diagnosed with the condition. The diagnosis of diabetes often necessitates the use of insulin and, by extension, pen needles. Pen needles are small, disposable, and fine-gauge needle designed to attach to insulin pens and similar devices for subcutaneous injections. It is primarily used for the administration of insulin by individuals with diabetes or other medical conditions requiring injectable therapies
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Pen Needles Market Size in 2022: | USD 2.1 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 10.6% |
2032 Value Projection: | USD 6.1 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 220 |
Tables, Charts & Figures: | 469 |
Segments covered: | Product, Application, Length, Distribution Channel, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|